WIRE: Cannabics gets final report on cannabinoids anti-tumor properties
TEL AVIV, Israel — Cannabics Pharmaceuticals Inc. (CNBX) is pleased to announce that it received the final report of the research held in the Technion Israel Institute [...]
anti-tumor
WIRE: Cannabics to provide cannabinoid anti-tumor tests for cancer patients
BETHESDA, Maryland — Cannabics Pharmaceuticals Inc. (CNBX) today announced it will begin providing personalized cannabinoid anti-tumor tests for cancer patients. The [...]